Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., West Virginia University 2000
• 

  Duke Appointment History

  • Assistant Consulting Professor of Child & Adolescent Psychiatry in the Department of Psychiatry and Behavioral Sciences, Psychiatry, Child & Family Mental Health and Developmental Neuroscience, Psychiatry & Behavioral Sciences 2007 - 2008
• Recognition
• 

  In the News

  • MAR 30, 2015

    Macleans

    The science is in: God is the answer
• Research
• 

  Selected Grants

  • Paternal Transgenerational Epigenetic Legacy from Use of Cannabis awarded by John Templeton Foundation 2017 - 2020
  • Purdue Adult Classroom awarded by Purdue Pharma 2018 - 2020
  • KP415.E01 Analog Classroom awarded by KemPharm, Inc 2017 - 2019
  • Neurobehavioral substrates of propranolol's effects on drug cue reactivity awarded by National Institutes of Health 2017 - 2019
  • SPD 489-348 Preschool Open Label Follow-Up awarded by Shire Pharmaceutical Development US Inc. 2015 - 2019
  • Environment Cue-Reactivity: Brain, Behavior and Clinical Outcomes in Tobacco Use awarded by National Institutes of Health 2014 - 2019
  • Pfizer Double-Blind 1017 awarded by Pfizer, Inc. 2018 - 2019
  • Pfizer Open Label 1019 awarded by Pfizer, Inc. 2018 - 2019
  • Behavioral and genetic mechanisms of smoking risk in individuals with ADHD awarded by National Institutes of Health 2012 - 2018
  • Rhodes Preschool pK awarded by Rhodes Pharmaceuticals L.P. 2015 - 2018
  • SPD489-211 Preschool pK Study awarded by Shire Pharmaceutical Development US Inc. 2015 - 2017
  • SEP360-202 awarded by Sunovion Pharmaceuticals, Inc 2015 - 2017
  • Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2015 - 2017
  • Ironshore_HLD200-108 awarded by Ironshore Pharmaceuticals & Development, Inc 2015 - 2016
  • An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2015 - 2016
  • SEP-225289 in Adults with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2014 - 2016
  • Neurovance_Adult Workplace Environment awarded by Neurovance 2015 - 2016
  • SEP-225289 in Subjects 6 to 17 Years of Age with Attention Deficit Hyperactivity Disorder awarded by Sunovion Pharmaceuticals, Inc 2015
  • Purdue Adolescent awarded by Purdue Pharma L.P. 2014 - 2015
  • Purdue Adult awarded by Purdue Pharma L.P. 2014 - 2015
  • Purdue Open Label awarded by Purdue Pharma L.P. 2014 - 2015
  • Ironshore Classroom Study awarded by Ironshore Pharmaceuticals & Development, Inc 2014 - 2015
  • Alcobra AL012 awarded by Alcobra Ltd. 2014 - 2015
  • Tris classroom awarded by Tris Pharma, Inc. 2014 - 2015
  • Neuropharmacology of Response Inhibition in Comorbid ADHD and Nicotine Dependence awarded by National Institutes of Health 2009 - 2014
  • Brain Substrates of Extinction-Based Treatment for Nicotine Dependence awarded by National Institutes of Health 2008 - 2014
  • Smoking reinforcement in adults with and without ADHD awarded by National Institutes of Health 2009 - 2012
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Kollins, SH, Schoenfelder, EN, English, JS, Holdaway, A, Van Voorhees, E, O'Brien, BR, Dew, R, and Chrisman, AK. "An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults." Journal of Substance Abuse Treatment 48, no. 1 (January 2015): 96-103.  Full Text
    • Kollins, SH, Schoenfelder, EN, English, JS, Holdaway, A, Van Voorhees, E, O'Brien, BR, Dew, R, and Chrisman, AK. "An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults." Journal of Substance Abuse Treatment 48, no. 1 (January 1, 2015): 96-103.  Full Text
    • Kollins, SH, English, JS, Itchon-Ramos, N, Chrisman, AK, Dew, R, O'Brien, B, and McClernon, FJ. "A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD." Journal of Attention Disorders 18, no. 2 (February 2014): 158-168.  Full Text
    • Kollins, SH, Schoenfelder, E, English, JS, McClernon, FJ, Dew, RE, and Lane, SD. "Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD)." Exp Clin Psychopharmacol 21, no. 5 (October 2013): 375-384.  Full Text  Link to Item
    • Bonelli, R, Dew, RE, Koenig, HG, Rosmarin, DH, and Vasegh, S. "Religious and spiritual factors in depression: Review and integration of the research." Depression Research and Treatment 2012 (December 1, 2012). (Review)  Full Text
    • Vasegh, S, Rosmarin, DH, Koenig, HG, Dew, RE, and Bonelli, RM. "Religious and spiritual factors in depression." Depression Research and Treatment 2012 (December 1, 2012). (Review)  Full Text
    • Van Voorhees, E, McClernon, FJ, Fuemmeler, B, English, J, Holdaway, A, Hallyburton, M, Dew, R, and Kollins, S. "An examination of differences in variables maintaining smoking behavior in adult smokers with and without attention-deficit/hyperactivity disorder." Addiction Research and Theory 20, no. 1 (February 1, 2012): 72-81.  Full Text
    • Blalock, L, and Dew, RE. "A pilot survey of clergy regarding mental health care for children." Depress Res Treat 2012 (2012): 742410-.  Full Text  Link to Item
    • Bidwell, LC, Dew, RE, and Kollins, SH. "Erratum: alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder." Curr Psychiatry Rep 13, no. 1 (February 2011): 76-.  Full Text  Link to Item
    • Dew, RE, and Kollins, SH. "Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD." Expert Opin Pharmacother 11, no. 17 (December 2010): 2907-2913. (Review)  Full Text  Link to Item
    • Cinnamon Bidwell, L, Dew, RE, and Kollins, SH. "Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder." Curr Psychiatry Rep 12, no. 5 (October 2010): 366-373. (Review)  Full Text  Link to Item
    • Dew, RE, Daniel, SS, Goldston, DB, McCall, WV, Kuchibhatla, M, Schleifer, C, Triplett, MF, and Koenig, HG. "A prospective study of religion/spirituality and depressive symptoms among adolescent psychiatric patients." Journal of Affective Disorders 120, no. 1-3 (January 2010): 149-157.  Full Text
    • Dew, RE. "Why Psychiatry Is the Hardest Specialty." American Journal of Psychiatry 166, no. 1 (January 2009): 16-17.  Full Text
    • Dew, RE, Daniel, SS, Armstrong, TD, Goldston, DB, Triplett, MF, and Koenig, HG. "Religion/Spirituality and adolescent psychiatric symptoms: a review." Child Psychiatry and Human Development 39, no. 4 (December 2008): 381-398. (Review)  Full Text
    • Dew, RE, Daniel, SS, Goldston, DB, and Koenig, HG. "Religion, spirituality, and depression in adolescent psychiatric outpatients." The Journal of Nervous and Mental Disease 196, no. 3 (March 2008): 247-251.  Full Text
    • Dougherty, DM, Dew, RE, Mathias, CW, Marsh, DM, Addicott, MA, and Barratt, ES. "Impulsive and premeditated subtypes of aggression in conduct disorder: differences in time estimation." Aggress Behav 33, no. 6 (November 2007): 574-582.  Full Text  Link to Item
    • Dew, RE, Daniel, SS, and Koenig, HG. "A pilot study on religiousness/spirituality and ADHD." Int J Adolesc Med Health 19, no. 4 (October 2007): 507-510.  Link to Item
    • Dew, RE. "Informed consent for research in Borderline Personality Disorder. (Published online)" BMC Med Ethics 8 (May 10, 2007): 4-.  Full Text  Link to Item
    • Dew, RE, Kramer, SI, and McCall, WV. "Adequacy of antidepressant treatment by psychiatric residents: the antidepressant treatment history form as a possible assessment tool." Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 29, no. 3 (July 2005): 283-288.  Full Text
    • Dew, RE, Rosenquist, PB, and McCall, WV. "Aripiprazole for agitation in a 13-year-old girl with neuroleptic malignant syndrome." Int J Adolesc Med Health 17, no. 2 (April 2005): 187-188.  Link to Item
    • Dew, RE, Kimball, JN, Rosenquist, PB, and McCall, WV. "Seizure length and clinical outcome in electroconvulsive therapy using methohexital or thiopental." J ECT 21, no. 1 (March 2005): 16-18.  Link to Item
    • Dew, RE, and Hughes, D. "Acute dystonic reaction with moderate-dose ziprasidone." J Clin Psychopharmacol 24, no. 5 (October 2004): 563-564. (Letter)  Link to Item
    • Dew, R, and McCall, WV. "Efficiency of outpatient ECT." J ECT 20, no. 1 (March 2004): 24-25.  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.